A randomized controlled clinical trial on the treatment of Thymosin a1 versus interferon-a in patients with hepatitis B

This publication has 30 references indexed in Scilit:

• A Randomized Controlled Trial of Thymosin–α1 Versus Interferon Alfa Treatment in Patients With Hepatitis B E Antigen Antibody—And Hepatitis B Virus Dna—Positive Chronic Hepatitis B
  Hepatology, 1996
• Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes.
  Journal of Clinical Investigation, 1996
• Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes
  Immunity, 1996
• Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: A major factor in activation of the host immune response to the hepatitis B virus
  Hepatology, 1995
• Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: A major factor in activation of the host immune response to the hepatitis B virus
  Hepatology, 1995
• Thymosin α1 treatment of chronic hepatitis B: A multicenter, randomized, placebo-controlled double blind study: MG Mutchnick, KL Lindsay, ER Schiff, GD Cummings, HD Appelman. Wayne State Univ., Detroit, MI; Univ. of S. Cal., L.A., CA; Univ. of Miami, Miami, FL; Univ. of Michigan, Ann Arbor, MI
  Gastroenterology, 1995
• Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial
  Journal of Hepatology, 1994
• Interferon in the management of chronic hepatitis B
  Digestive Diseases and Sciences, 1993
• Treatment of chronic carriers of woodchuck hepatitis virus infection with thymosin alpha-1
  Antiviral Research, 1991
• Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study
  Journal of Hepatology, 1990